Location of Repository

Prospects for using meloxicam in old-age group patients with rheumatic diseases

By O N Egorova and R M BalabanovaO N Egorova and R M Balabanova

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used in complex therapy for pain syndrome in rheumatology. The paper describes the pathophysiological mechanisms responsible for the development of chronic and acute pain. It details the action of cyclooxygenase types 1 and 2 (COG 1 and COG 2), shows the key role of COG 2 in pain induction and transmission. The data of clinical trials of meloxicam that inhibits mainly COG 2 are given. The drug is highly effective in treating rheumatic diseases, particularly in old-age group patients with osteoporosis. The combined use of different meloxicam formulations makes it possible to choose adequate, maximally individualized treatment and to relieve the pain syndrome in the shortest possible time. Among NSAIDs, meloxicam shows an optimum efficacy-safety ratio

Topics: Medicine, R
Publisher: IMA-PRESS LLC
Year: 2008
OAI identifier: oai:doaj.org/article:ede50fe9fd6e4d318d91ca978353c7fa
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2310-158X (external link)
  • https://doaj.org/toc/1996-7012 (external link)
  • http://mrj.ima-press.net/mrj/a... (external link)
  • https://doaj.org/article/ede50... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.